Jane Street »

Calidi Biotherapeutics shares owned by Jane Street

Quarter-by-quarter ownership of Calidi Biotherapeutics (CLDI) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Calidi Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Calidi Biotherapeutics held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calidi Biotherapeutics by Jane Street

Quarter filed Position value Share count Share price at filing
2025-12-31 $13k 12k 1.17

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for Jane Street

Top funds holding Calidi Biotherapeutics

DRW Holdings
HighTower Advisors
Geode Capital Management
Vanguard Group
Virtu Financial
Rs Crum
Belpointe Asset Management
Northern Trust
Jane Street
Farther Finance Advisors
UBS Group
Tower Research Capital
Advisor Group Holdings
Finepoint Capital
Apollo Management Holdings

View all funds holding Calidi Biotherapeutics